Li et al. [23] proved that hepatocyte growth factor (HGF) is a downstream effector that mediates the antifibrotic action of peroxisome proliferator–activated receptor-γ agonists in their study on renal fibrosis lesions. Here, HGF is linked to renal fibrosis.